首页> 美国卫生研究院文献>Infection and Immunity >Effects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cells.
【2h】

Effects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cells.

机译:内源性和外源性抑制剂对人单核细胞将标记的前体掺入DNA的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The degree of responsiveness of lymphoid cells to activation by mitogens and antigens is commonly assessed in vitro by measuring radioactive DNA precursor incorporation. Several lines of evidence indicate that artifacts affect the results and that these measurements may not be an accurate reflection of cell activation. Cultures of blastogenically activated lymphocytes contain soluble, noncytotoxic factors that inhibit the incorporation of radioactive nucleosides into DNA by dividing cells without affecting their rate of DNA synthesis. Inhibitors were found in the serum component of the medium and in the bacterial homogenates used to activate the cells, and they were produced by the activated cells. Inhibitor activity in serum has properties expected of a nucleoside such as thymidine, including a molecular weight of less than 10(3). The inhibitor activity present in some bacterial homogenates and that produced by activated cells enzymically degrade labeled DNA precursors, thereby preventing their availability for incorporation. Other bacterial preparations contain DNA precursors, which compete with labeled nucleosides for incorporation, and additional low-molecular-weight inhibitor is produced when the preparations are incubated. Preparations of various bacteria differ greatly with regard to the potency of their inhibitor activity. In some cases incorporation of label in activated cultures is reduced to background levels. Inhibition by these substances leads to erroneous conclusions regarding the proliferative activity of cultured lymphocytes, since the amount of label incorporated does not accurately indicate the true rate of DNA synthesis of the cells.
机译:通常在体外通过测量放射性DNA前体的掺入来评估淋巴样细胞对有丝分裂原和抗原激活的响应度。有几条证据表明,伪影会影响结果,这些测量结果可能无法准确反映细胞活化。胚细胞活化的淋巴细胞培养物中含有可溶的,无细胞毒性的因子,可通过分裂细胞来抑制放射性核苷掺入DNA,而不会影响其DNA合成速率。在培养基的血清成分和用于活化细胞的细菌匀浆中发现了抑制剂,它们是由活化的细胞产生的。血清中的抑制剂活性具有预期的核苷(如胸腺嘧啶核苷)特性,包括小于10(3)的分子量。存在于某些细菌匀浆中的抑制剂活性和被活化细胞产生的抑制剂活性会通过酶降解标记的DNA前体,从而阻止其掺入。其他细菌制剂包含DNA前体,可与标记的核苷竞争掺入,并且在孵育该制剂时会产生其他低分子量抑制剂。各种细菌的制剂在其抑制剂活性的效力方面差异很大。在某些情况下,标记物在活化培养物中的掺入降低到背景水平。由于掺入的标记物的数量不能准确地表明细胞的DNA合成的真实速度,因此这些物质的抑制作用会导致有关培养的淋巴细胞增殖活性的错误结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号